Literature DB >> 12791211

Viral otitis media.

Craig A Buchman1, George M Brinson.   

Abstract

Acute otitis media (AOM) and viral upper respiratory tract infections (URIs) represent the two most common diseases affecting the human population, and account for substantial patient morbidity and health care costs. Epidemiologic and experimental studies suggest that URIs play a causal role in the pathogenesis of AOM. Specifically, viruses can either invade the middle ear (ME) space and invoke an inflammatory response that culminates in ME effusion formation and consequent symptoms, or URIs might cause eustachian-tube dysfunction, resulting in negative ME pressures and subsequent ME effusion (hydrops ex vacuo theory). The events responsible for the inflammatory response of the human ME following viral exposure have not been well characterized. Although many prophylactic and therapeutic interventions have been evaluated for the treatment of AOM, the information on virus-specific interventions is sparse. In this article, the epidemiology, pathogenesis, diagnosis, and management of viral otitis media are reviewed.

Entities:  

Mesh:

Year:  2003        PMID: 12791211      PMCID: PMC7088597          DOI: 10.1007/s11882-003-0094-6

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  50 in total

1.  Detection of respiratory viruses in the middle ear fluids of children with acute otitis media by multiplex reverse transcription:polymerase chain reaction assay.

Authors:  T Chonmaitree; K J Henrickson
Journal:  Pediatr Infect Dis J       Date:  2000-03       Impact factor: 2.129

2.  Prevention of otitis media in children with live attenuated influenza vaccine given intranasally.

Authors:  R B Belshe; W C Gruber
Journal:  Pediatr Infect Dis J       Date:  2000-05       Impact factor: 2.129

3.  Are antibiotics indicated as initial treatment for children with acute otitis media? A meta-analysis.

Authors:  C Del Mar; P Glasziou; M Hayem
Journal:  BMJ       Date:  1997-05-24

4.  Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study.

Authors:  D W Teele; J O Klein; B Rosner
Journal:  J Infect Dis       Date:  1989-07       Impact factor: 5.226

Review 5.  Decongestants and antihistamines for acute otitis media in children.

Authors:  C A Flynn; G Griffin; F Tudiver
Journal:  Cochrane Database Syst Rev       Date:  2002

Review 6.  Immune responses of infants to infection with respiratory viruses and live attenuated respiratory virus candidate vaccines.

Authors:  J E Crowe
Journal:  Vaccine       Date:  1998 Aug-Sep       Impact factor: 3.641

7.  Influenza vaccination in the prevention of acute otitis media in children.

Authors:  T Heikkinen; O Ruuskanen; M Waris; T Ziegler; M Arola; P Halonen
Journal:  Am J Dis Child       Date:  1991-04

Review 8.  Acute otitis media: management and surveillance in an era of pneumococcal resistance--a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group.

Authors:  S F Dowell; J C Butler; G S Giebink; M R Jacobs; D Jernigan; D M Musher; A Rakowsky; B Schwartz
Journal:  Pediatr Infect Dis J       Date:  1999-01       Impact factor: 2.129

9.  Prevalence of various respiratory viruses in the middle ear during acute otitis media.

Authors:  T Heikkinen; M Thint; T Chonmaitree
Journal:  N Engl J Med       Date:  1999-01-28       Impact factor: 91.245

10.  Safety and efficacy of intranasal pirodavir (R77975) in experimental rhinovirus infection.

Authors:  F G Hayden; K Andries; P A Janssen
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

View more
  2 in total

Review 1.  Measuring the Possibility of Middle Ear Discharge for COVID-19 Test Material.

Authors:  Hamsu Kadriyan; Lalu Hizrian Rizkika Abtartu; Eustachius Hagni Wardoyo; Fahrin Ramadan Andiwijaya
Journal:  Interdiscip Perspect Infect Dis       Date:  2022-04-20

Review 2.  Otitis media.

Authors:  Anne G M Schilder; Tasnee Chonmaitree; Allan W Cripps; Richard M Rosenfeld; Margaretha L Casselbrant; Mark P Haggard; Roderick P Venekamp
Journal:  Nat Rev Dis Primers       Date:  2016-09-08       Impact factor: 52.329

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.